Encapsulation of curcumin in diblock copolymer micelles for cancer therapy

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Alizadeh, Ali Mohammad ^a   Sadeghizadeh, Majid ^b   Najafi, Farhood ^c   Ardestani, Sussan K ^d   Erfani Moghadam, Vahid ^e   Khaniki, Mahmood ^f   Rezaei, Arezou ^g   Zamani, Mina ^b   Khodayari, Saeed ^a   Khodayari, Hamid ^a   Mohagheghi, Mohammad Ali ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c INSTITUTE FOR COLOR SCIENCE AND TECHNOLOGY   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

^e GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g DAMGHAN UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; NANOCARRIER; PROTEIN BAX; PROTEIN BCL 2; ANTINEOPLASTIC AGENT; DRUG CARRIER; MICELLE; NANOPARTICLE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; BREAST CANCER; CANCER CELL CULTURE; CANCER THERAPY; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DIARRHEA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MICELLE; MOUSE; NANOENCAPSULATION; NEPHROTOXICITY; NONHUMAN; PARTICLE SIZE; PROTEIN EXPRESSION; TUMOR VOLUME; WEIGHT REDUCTION; ZETA POTENTIAL; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL PROLIFERATION; DRUG EFFECTS; DRUG STABILITY; LIVER NEOPLASMS; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; DRUG CARRIERS; DRUG STABILITY; FEMALE; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICELLES; NANOPARTICLES; POLYMERS;

EID: 84924565328     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/824746     Document Type: Article

References (78)

1. M. Bayet-Robert and D. Morvan, "Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel," PLoS ONE, Vol. 8, no. 3, Article ID e57971, 2013.
2. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal, "Bioavailability of curcumin: problems and promises," Molecular Pharmaceutics, Vol. 4, no. 6, pp. 807-818, 2007.
3. M. Kakarala, D. E. Brenner, H. Korkaya et al., "Targeting breast stem cells with the cancer preventive compounds curcumin and piperine," Breast Cancer Research and Treatment, Vol. 122, no. 3, pp. 777-785, 2010.
4. S. S. Dhule, P. Penfornis, T. Frazier et al., "Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma," Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 8, no. 4, pp. 440-451, 2012.
5. N. Ghalandarlaki, A. M. Alizadeh, and S. Ashkani-Esfahani, "Nanotechnology-applied curcumin for different diseases therapy," BioMed Research International, Vol. 2014, Article ID 394264, 23 pages, 2014.
6. T. G. Shutava, S. S. Balkundi, P. Vangala et al., "Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols," ACS Nano, Vol. 3, no. 7, pp. 1877-1885, 2009.
7. B. Le Droumaguet, J. Nicolas, D. Brambilla et al., "Versatile and eficient targeting using a single nanoparticulate platform: application to cancer and alzheimer's disease," ACS Nano, Vol. 6, no. 7, pp. 5866-5879, 2012.
8. F. D. Ledley, "Nonviral gene therapy: the promise of genes as pharmaceutical products," Human Gene Therapy, Vol. 6, no. 9, pp. 1129-1144, 1995.
9. N. Suwannateep, S. Wanichwecharungruang, S. F. Haag et al., "Encapsulated curcumin results in prolonged curcumin activity in vitro and radical scavenging activity ex vivo on skin after UVB-irradiation," European Journal of Pharmaceutics and Biopharmaceutics, Vol. 82, no. 3, pp. 485-490, 2012.
10. E. Babaei, M. Sadeghizadeh, Z. M. Hassan, M. A. H. Feizi, F. Najafi, and S. M. Hashemi, "Dendrosomal curcumin signifi-cantly suppresses cancer cell proliferation in vitro and in vivo," International Immunopharmacology, Vol. 12, no. 1, pp. 226-234, 2012.
11. M. Khaniki, S. Azizian, A. M. Alizadeh, H. Hemmati, N. Emamipour, and M. A. Mohagheghi, "The antiproliferative and anti-cancerogenic effects of nano-curcumin in rat colon cancer," Tehran University Medical Journal, Vol. 71, no. 5, pp. 277-284, 2013.
12. M. N. Sarbolouki, A. M. Alizadeh, M. Khaniki, S. Azizian, and M. A. Mohaghgheg, "Protective effect of dendrosomal cur-cumin combination on colon cancer in rat," Tehran University Medical Journal, Vol. 69, no. 11, pp. 678-685, 2012.
13. M. T. Mirgani, B. Isacchi, M. Sadeghizadeh et al., "Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells," International Journal of Nanomedicine, Vol. 9, no. 1, pp. 403-417, 2014.
14. A. Sahu, U. Bora, N. Kasoju, and P. Goswami, "Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells," Acta Biomaterialia, Vol. 4, no. 6, pp. 1752-1761, 2008.
15. S. Bisht, G. Feldmann, S. Soni, R. Ravi, C. Karikar, and A. Maitra, "Polymeric nanoparticle-encapsulated curcumin ("nanocur-cumin"): a novel strategy for human cancer therapy," Journal of Nanobiotechnology, Vol. 5, article 3, 2007.
16. Z. Ma, A. Haddadi, O. Molavi, A. Lavasanifar, R. Lai, and J. Samuel, "Micelles of poly(ethylene oxide)-b-poly(ε-capro-lactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin," Journal of Biomedical Materials Research Part A, Vol. 86, no. 2, pp. 300-310, 2008.
17. M. Gou, K. Men, H. Shi et al., "Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo," Nanoscale, Vol. 3, no. 4, pp. 1558-1567, 2011.
18. L. Song, Y. Shen, J. Hou, L. Lei, S. Guo, and C. Qian, "Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation," Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 390, no. 1-3, pp. 25-32, 2011.
19. T. Mosmann, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays," Journal of Immunological Methods, Vol. 65, no. 1-2, pp. 55-63, 1983.
20. R. A. Sharma, A. J. Gescher, and W. P. Steward, "Curcumin: the story so far," European Journal of Cancer, Vol. 41, no. 13, pp. 1955-1968, 2005.
21. M. Mohsenikia, A. M. Alizadeh, S. Khodayari et al., "The protective and therapeutic effects of alpha-solanine on mice breast cancer," European Journal of Pharmacology, Vol. 718, no. 1-3, pp. 1-9, 2013.
22. A. M. Alizadeh, M. Faghihi, V. Khori et al., "Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore," Peptides, Vol. 36, no. 1, pp. 71-77, 2012.
23. J.-L. Achard, I. van Praagh, and V. Feillel, "Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosen-sitivity in invasive ductal breast carcinomas treated by neoadju-vant chemotherapy," International Journal of Oncology, Vol. 20, no. 4, pp. 791-796, 2002.
24. A. M. Alizadeh, M. Khaniki, S. Azizian, M. A. Mohaghgheghi, M. Sadeghizadeh, and F. Najafi, "Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin," European Journal of Pharmacology, Vol. 689, no. 1-3, pp. 226-232, 2012.
25. A. Vila, A. Sánchez, M. Tobío, P. Calvo, and M. J. Alonso, "Design of biodegradable particles for protein delivery," Journal of Controlled Release, Vol. 78, no. 1-3, pp. 15-24, 2002.
26. R. H. Müller, C. Jacobs, and O. Kayser, "Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future," Advanced Drug Delivery Reviews, Vol. 47, no. 1, pp. 3-19, 2001.
27. J. Ravindran, S. Prasad, and B. B. Aggarwal, "Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?" AAPS Journal, Vol. 11, no. 3, pp. 495-510, 2009.
28. Y.-J. Wang, M.-H. Pan, A.-L. Cheng et al., "Stability of curcumin in buffer solutions and characterization of its degradation products," Journal of Pharmaceutical and Biomedical Analysis, Vol. 15, no. 12, pp. 1867-1876, 1997.
29. J. Heyes, K. Hall, V. Tailor, R. Lenz, and I. MacLachlan, "Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery," Journal of Controlled Release, Vol. 112, no. 2, pp. 280-290, 2006.
30. X. Wei, C. Gong, M. Gou et al., "Biodegradable poly(ε-capro-lactone)-poly(ethylene glycol) copolymers as drug delivery system," International Journal of Pharmaceutics, Vol. 381, no. 1, pp. 1-18, 2009.
31. K. Maeda, Y.-S. Chung, S. Takatsuka et al., "Tumour angiogen-esis and tumour cell proliferation as prognostic indicators in gastric carcinoma," British Journal of Cancer, Vol. 72, no. 2, pp. 319-323, 1995.
32. J.-M. Zingg, S. T. Hasan, and M. Meydani, "Molecular mechanisms of hypolipidemic effects of curcumin," BioFactors, Vol. 39, no. 1, pp. 101-121, 2013.
33. E. C. M. Mommers, P. J. van Diest, A. M. Leonhart, C. J. L. M. Meijer, and J. P. A. Baak, "Balance of cell proliferation and apoptosis in breast carcinogenesis," Breast Cancer Research and Tre atment, Vol. 58, no. 2, pp. 163-169, 1999.
34. J. B. Baell and D. C. S. Huang, "Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs," Biochemical Pharmacology, Vol. 64, no. 5-6, pp. 851-863, 2002.
35. D. Karunagaran, R. Rashmi, and T. R. Santhosh Kumar, "Induction of apoptosis by curcumin and its implications for cancer therapy," Current Cancer Drug Targets, Vol. 5, no. 2, pp. 117-129, 2005.
36. R. J. Anto, A. Mukhopadhyay, K. Denning, and B. B. Aggarwal, "Curcumin (differuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl," Carcinogenesis, Vol. 23, no. 1, pp. 143-150, 2002.
37. J. Folkman, "What is the evidence that tumors are angiogenesis dependent?" Journal of the National Cancer Institute, Vol. 82, no. 1, pp. 4-6, 1990.
38. S. B. Fox, D. G. Generali, and A. L. Harris, "Breast tumour angiogenesis," Breast Cancer Research, Vol. 9, no. 6, article 216, 2007.
39. P. Anand, H. B. Nair, B. Sung et al., "Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavail-ability in vivo," Biochemical Pharmacology, Vol. 79, no. 3, pp. 330-338, 2010.
40. M. Bayet-Robert and D. Morvan, "Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel," PLoS ONE, Vol. 8, no. 3, Article ID e57971, 2013.
41. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal, "Bioavailability of curcumin: problems and promises," Molecular Pharmaceutics, Vol. 4, no. 6, pp. 807-818, 2007.
42. M. Kakarala, D. E. Brenner, H. Korkaya et al., "Targeting breast stem cells with the cancer preventive compounds curcumin and piperine," Breast Cancer Research and Treatment, Vol. 122, no. 3, pp. 777-785, 2010.
43. S. S. Dhule, P. Penfornis, T. Frazier et al., "Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma," Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 8, no. 4, pp. 440-451, 2012.
44. N. Ghalandarlaki, A. M. Alizadeh, and S. Ashkani-Esfahani, "Nanotechnology-applied curcumin for different diseases therapy," BioMed Research International, Vol. 2014, Article ID 394264, 23 pages, 2014.
45. T. G. Shutava, S. S. Balkundi, P. Vangala et al., "Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols," ACS Nano, Vol. 3, no. 7, pp. 1877-1885, 2009.
46. B. Le Droumaguet, J. Nicolas, D. Brambilla et al., "Versatile and eficient targeting using a single nanoparticulate platform: application to cancer and alzheimer's disease," ACS Nano, Vol. 6, no. 7, pp. 5866-5879, 2012.
47. F. D. Ledley, "Nonviral gene therapy: the promise of genes as pharmaceutical products," Human Gene Therapy, Vol. 6, no. 9, pp. 1129-1144, 1995.
48. N. Suwannateep, S. Wanichwecharungruang, S. F. Haag et al., "Encapsulated curcumin results in prolonged curcumin activity in vitro and radical scavenging activity ex vivo on skin after UVB-irradiation," European Journal of Pharmaceutics and Biopharmaceutics, Vol. 82, no. 3, pp. 485-490, 2012.
49. E. Babaei, M. Sadeghizadeh, Z. M. Hassan, M. A. H. Feizi, F. Najafi, and S. M. Hashemi, "Dendrosomal curcumin signifi-cantly suppresses cancer cell proliferation in vitro and in vivo," International Immunopharmacology, Vol. 12, no. 1, pp. 226-234, 2012.
50. M. Khaniki, S. Azizian, A. M. Alizadeh, H. Hemmati, N. Emamipour, and M. A. Mohagheghi, "The antiproliferative and anti-cancerogenic effects of nano-curcumin in rat colon cancer," Tehran University Medical Journal, Vol. 71, no. 5, pp. 277-284, 2013.
51. M. N. Sarbolouki, A. M. Alizadeh, M. Khaniki, S. Azizian, and M. A. Mohaghgheg, "Protective effect of dendrosomal cur-cumin combination on colon cancer in rat," Tehran University Medical Journal, Vol. 69, no. 11, pp. 678-685, 2012.
52. M. T. Mirgani, B. Isacchi, M. Sadeghizadeh et al., "Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells," International Journal of Nanomedicine, Vol. 9, no. 1, pp. 403-417, 2014.
53. A. Sahu, U. Bora, N. Kasoju, and P. Goswami, "Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells," Acta Biomaterialia, Vol. 4, no. 6, pp. 1752-1761, 2008.
54. S. Bisht, G. Feldmann, S. Soni, R. Ravi, C. Karikar, and A. Maitra, "Polymeric nanoparticle-encapsulated curcumin ("nanocur-cumin"): a novel strategy for human cancer therapy," Journal of Nanobiotechnology, Vol. 5, article 3, 2007.
55. Z. Ma, A. Haddadi, O. Molavi, A. Lavasanifar, R. Lai, and J. Samuel, "Micelles of poly(ethylene oxide)-b-poly(ε-capro-lactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin," Journal of Biomedical Materials Research Part A, Vol. 86, no. 2, pp. 300-310, 2008.
56. M. Gou, K. Men, H. Shi et al., "Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo," Nanoscale, Vol. 3, no. 4, pp. 1558-1567, 2011.
57. L. Song, Y. Shen, J. Hou, L. Lei, S. Guo, and C. Qian, "Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation," Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 390, no. 1-3, pp. 25-32, 2011.
58. T. Mosmann, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays," Journal of Immunological Methods, Vol. 65, no. 1-2, pp. 55-63, 1983.
59. R. A. Sharma, A. J. Gescher, and W. P. Steward, "Curcumin: the story so far," European Journal of Cancer, Vol. 41, no. 13, pp. 1955-1968, 2005.
60. M. Mohsenikia, A. M. Alizadeh, S. Khodayari et al., "The protective and therapeutic effects of alpha-solanine on mice breast cancer," European Journal of Pharmacology, Vol. 718, no. 1-3, pp. 1-9, 2013.
61. A. M. Alizadeh, M. Faghihi, V. Khori et al., "Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore," Peptides, Vol. 36, no. 1, pp. 71-77, 2012.
62. J.-L. Achard, I. van Praagh, and V. Feillel, "Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosen-sitivity in invasive ductal breast carcinomas treated by neoadju-vant chemotherapy," International Journal of Oncology, Vol. 20, no. 4, pp. 791-796, 2002.
63. A. M. Alizadeh, M. Khaniki, S. Azizian, M. A. Mohaghgheghi, M. Sadeghizadeh, and F. Najafi, "Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin," European Journal of Pharmacology, Vol. 689, no. 1-3, pp. 226-232, 2012.
64. A. Vila, A. Sánchez, M. Tobío, P. Calvo, and M. J. Alonso, "Design of biodegradable particles for protein delivery," Journal of Controlled Release, Vol. 78, no. 1-3, pp. 15-24, 2002.
65. R. H. Müller, C. Jacobs, and O. Kayser, "Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future," Advanced Drug Delivery Reviews, Vol. 47, no. 1, pp. 3-19, 2001.
66. J. Ravindran, S. Prasad, and B. B. Aggarwal, "Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?" AAPS Journal, Vol. 11, no. 3, pp. 495-510, 2009.
67. Y.-J. Wang, M.-H. Pan, A.-L. Cheng et al., "Stability of curcumin in buffer solutions and characterization of its degradation products," Journal of Pharmaceutical and Biomedical Analysis, Vol. 15, no. 12, pp. 1867-1876, 1997.
68. J. Heyes, K. Hall, V. Tailor, R. Lenz, and I. MacLachlan, "Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery," Journal of Controlled Release, Vol. 112, no. 2, pp. 280-290, 2006.
69. X. Wei, C. Gong, M. Gou et al., "Biodegradable poly(ε-capro-lactone)-poly(ethylene glycol) copolymers as drug delivery system," International Journal of Pharmaceutics, Vol. 381, no. 1, pp. 1-18, 2009.
70. K. Maeda, Y.-S. Chung, S. Takatsuka et al., "Tumour angiogen-esis and tumour cell proliferation as prognostic indicators in gastric carcinoma," British Journal of Cancer, Vol. 72, no. 2, pp. 319-323, 1995.
71. J.-M. Zingg, S. T. Hasan, and M. Meydani, "Molecular mechanisms of hypolipidemic effects of curcumin," BioFactors, Vol. 39, no. 1, pp. 101-121, 2013.
72. E. C. M. Mommers, P. J. van Diest, A. M. Leonhart, C. J. L. M. Meijer, and J. P. A. Baak, "Balance of cell proliferation and apoptosis in breast carcinogenesis," Breast Cancer Research and Tre atment, Vol. 58, no. 2, pp. 163-169, 1999.
73. J. B. Baell and D. C. S. Huang, "Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs," Biochemical Pharmacology, Vol. 64, no. 5-6, pp. 851-863, 2002.
74. D. Karunagaran, R. Rashmi, and T. R. Santhosh Kumar, "Induction of apoptosis by curcumin and its implications for cancer therapy," Current Cancer Drug Targets, Vol. 5, no. 2, pp. 117-129, 2005.
75. R. J. Anto, A. Mukhopadhyay, K. Denning, and B. B. Aggarwal, "Curcumin (differuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl," Carcinogenesis, Vol. 23, no. 1, pp. 143-150, 2002.
76. J. Folkman, "What is the evidence that tumors are angiogenesis dependent?" Journal of the National Cancer Institute, Vol. 82, no. 1, pp. 4-6, 1990.
77. S. B. Fox, D. G. Generali, and A. L. Harris, "Breast tumour angiogenesis," Breast Cancer Research, Vol. 9, no. 6, article 216, 2007.
78. P. Anand, H. B. Nair, B. Sung et al., "Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavail-ability in vivo," Biochemical Pharmacology, Vol. 79, no. 3, pp. 330-338, 2010.